MedPath

Diagnosis of HCM With AI-ECG

Recruiting
Conditions
Hypertrophic Cardiomyopathy
Registration Number
NCT06287892
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

The study aims to establish a diagnostic model of hypertrophic cardiomyopathy with artificial intelligence-enhanced electrocardiogram.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • Diagnosed with HCM
Exclusion Criteria
  • Patients with ventricular pacing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnosis of HCM with AI-ECG1 year within the time frame of ECG data collection

First a diagnosis of HCM is made as the standard outcome according to 1) an International Classification of Diseases (ICD) code for HCM (ICD-9425.1, 425.11, 425.18, and ICD10 I42.1, I42.2); 2) reports from the echocardiographers.

An AI-ECG algorithm will be used to make a diagnosis of HCM and compared with the standard outcome.

The performance of the AI-ECG algorithm will be evaluated with metrics including AU-ROC, specificity, sensitivity and F1 value.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

180 Fenglin Road

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath